Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Wittbrodt ET, Eudicone JM, Bell KF, Enhoffer DM, et al. Eligibility varies among the 4 sodium-glucose cotransporter-2 inhibitor cardiovascular outcomes trials: implications for the general type 2 diabetes US population. Am J Manag Care 2018;24.
PMID: 29693360


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016